Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best approach 2-6 to care pathways using mobile technology in AR and asthma multimorbidity 7. ARIA appears to be close to the patient’s needs but real life data obtained using an App in 22 countries have shown that very few patients use guidelines and that they often self-medicate (Bousquet, in preparation). Moreover, patients largely use OTC medications dispensed in pharmacies 8-10. Shared decision making (SDM) centered around the patient should be used more often. ARIA has followed a change management (CM) strategy but a new one should be considered to fill the gaps in order to increase the benefits of self-medication and SDM in care pathways using the 11. currently-available IT tools These changes should prepare and support individuals, teams and organizations in making organizational change centered around the patient. 1- Background 1-1- The four ARIA phases ARIA was initiated during a World Health Organization (WHO) workshop in 1999 (published in 2001) and has evolved in four phases (Figure 1): Phase 1: Development of an evidence-based document to provide a guide for the diagnosis and management of AR and asthma multimorbidity including developing countries 2,3. It was implemented by the WHO Collaborating Center for Asthma and Rhinitis (Montpellier). In 2008, ARIA was updated using the same recommendation system 2,12. ARIA has been disseminated and is implemented in over 70 countries around the world 13. 2: In its 2010 Revision, ARIA was the first chronic respiratory disease guideline to adopt the GRADE (Grading of Recommendation, Assessment, Development and Evaluation) approach, an advanced evidence evaluation methodology 4-6. Phase 3: ARIA focussed on the implementation of emerging technologies for individualized and predictive medicine to develop care pathways for the management of AR and asthma by a group which included patients 14-20 (MASK: MACVIA (Contre les MAladies Sentinel Network). Chroniques pour un VIeillissement Actif)-ARIA The next phase is change management. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle whatever their sex or socio-economic status in order to reduce health and social inequities incurred by the disease. Figure 1: The 4 Phases of ARIA
Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best approach 2-6 to care pathways using mobile technology in AR and asthma multimorbidity 7. ARIA appears to be close to the patient’s needs but real life data obtained using an App in 22 countries have shown that very few patients use guidelines and that they often self-medicate (Bousquet, in preparation). Moreover, patients largely use OTC medications dispensed in pharmacies 8-10. Shared decision making (SDM) centered around the patient should be used more often. ARIA has followed a change management (CM) strategy but a new one should be considered to fill the gaps in order to increase the benefits of self-medication and SDM in care pathways using the currently-available IT tools 11. These changes should prepare and support individuals, teams and organizations in making organizational change centered around the patient. 1- Background 1-1- The four ARIA phases ARIA was initiated during a World Health Organization (WHO) workshop in 1999 (published in 2001) and has evolved in four phases (Figure 1): Phase 1: Development of an evidence-based document to provide a guide for the diagnosis and management of AR and asthma multimorbidity including developing countries 2,3. It was implemented by the WHO Collaborating Center for Asthma and Rhinitis (Montpellier). In 2008, ARIA was updated using the same recommendation system 2,12. ARIA has been disseminated and is implemented in over 70 countries around the world 13. 2: In its 2010 Revision, ARIA was the first chronic respiratory disease guideline to adopt the GRADE (Grading of Recommendation, Assessment, Development and Evaluation) approach, an advanced evidence evaluation methodology 4-6. Phase 3: ARIA focussed on the implementation of emerging technologies for individualized and predictive medicine to develop care pathways for the management of AR and asthma by a group which included patients 14-20 (MASK: MACVIA (Contre les MAladies Chroniques pour un VIeillissement Actif)-ARIA Sentinel Network). The next phase is change management. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle whatever their sex or socio-economic status in order to reduce health and social inequities incurred by the disease. Figure 1: The 4 Phases of ARIA
Attachment.1.a.-ARIA-change-management-30-12.docx